Table 1 |
Table 1 |
Table 1 |
Table
1 |
|
Usual Care
N=100
|
Protocol Guided
N=100
|
P value
|
Age |
62.0±11.2 |
59.5±10.6 |
0.122 |
Race, n (%) |
|
|
|
Caucasian (%)
|
89 (89)
|
91 (91)
|
|
Black (%)
|
5 (5)
|
4 (4)
|
|
Asian (%)
|
2 (2)
|
1 (1)
|
|
Other (%)
|
4 (4)
|
4 (4)
|
|
Male, n (%) |
75 (75) |
69 (69) |
0.345 |
BMI (kg/m2) |
31.0±5.7 |
31.3±5.9 |
0.590 |
Antiplatelet, n (%) |
|
|
|
Aspirin
|
42 (42)
|
42 (42)
|
1.0
|
Clopidogrel
|
4 (4)
|
4 (4)
|
1.0
|
Comorbidities, n (%) |
|
|
|
CHF
|
18 (18)
|
10 (10)
|
0.103
|
DM
|
16 (16)
|
13 (13)
|
0.547
|
Stroke
|
19 (19)
|
12 (12)
|
0.171
|
PAD
|
7 (7)
|
5 (5)
|
0.552
|
CAD
|
20 (20)
|
15 (15)
|
0.352
|
HTN
|
67 (67)
|
66 (66)
|
0.881
|
GFR (mL/min/1.73m2) |
81±15 |
80±16 |
0.559 |
LVEF (%) |
57±7 |
58±9 |
0.210 |